Objective-To examine neuropsychologi-
Alzheimer's disease and dementia in Parkinson's disease have been considered the most frequent types of cortical and subcortical dementia respectively.
Cummings and Benson' suggested that there should be differences in cognitive, emotional, and motor impairments in cortical and subcortical dementias. In cortical dementias cognitive deficits are characterised by impairments in language and memory, agnosia, and apraxia. In subcortical dementias, cognitive deficits are characterised by a general slowness of thought processes, and impaired manipulation of acquired knowledge (for example, deficits in abstracting abilities, retrieval, and visuospatial functions). Cummings and Benson further suggested that lack of concern (anosognosia) and disinhibition may be more frequent in cortical dementias, whereas apathy or depression may be more prevalent in subcortical dementias.' Finally, they also pointed out that although motor abnormalities may be absent in cortical dementias, disorders of movement, tone, posture, and gait are universal in subcortical dementias.
None the less, the classification of the dementias into cortical and subcortical types is a controversial issue. Several authors suggested that this classification scheme should be abandoned,23 because at necropsy, brains of patients with cortical dementias also feature subcortical pathological change (for example, depletion of cholinergic neurons in the nucleus basalis of Meynert in Alzheimer's disease), and similarly, brains of patients with subcortical dementias may also show cortical damage (for example, cortical atrophy in Huntington's disease).' Another confounding issue is that cortical and subcortical dementias may coexist in the same patient. For example, several studies reported patients with Parkinson's disease and dementia who also showed the characteristic neuropathological features of Alzheimer's disease. 4 Neuropsychological differences between patients with Alzheimer's disease and demented patients with Parkinson's disease have been examined in several studies. Whereas Mayeux et al could not find significant differences between patients with Alzheimer's disease and demented patients with Parkinson's disease on a test of global cognitive functions,5 studies using more detailed neuropsychological assessments showed significant between group differences.6 7Affective changes have also been reported in both Alzheimer's disease and Parkinson's disease. Most studies showed either dysthymia or major depression in about one third of patients with Parkinson's disease,8 and a similar prevalence of depression has been reported in Alzheimer's disease.9 However, the prevalence of depression among patients with Parkinson's disease and dementia has not been examined, and to our knowledge, whether affective disorders have a different prevalence in Alzheimer's disease and patients with Parkinson's disease and dementia has not been assessed. Moreover, whereas Cummings and Benson' speculated that patients with Alzheimer's disease may be more anosognosic than demented patients with Parkinson's disease, this hypothesis has not been empirically examined.
Motor disorders such as tremor, rigidity, and akinesia are the hallmark of Parkinson's disease, but they are also present in about a quarter of patients with Alzheimer's disease.'0 In a recent study, we showed significant cognitive and psychiatric differences between patients with Alzheimer's disease with or without extrapyramidal motor signs." Thus to compare cognitive and psychiatric functioning in patients with Alzheimer's disease and patients with Parkinson's disease and dementia it is important to screen patients with Alzheimer's disease for the presence of extrapyramidal signs.
Finally, to our knowledge studies using the same comprehensive neuropsychological, neuropsychiatric, and neurological assessments in cohorts of Alzheimer's disease and demented patients with Parkinson's disease have not been carried out. This was the aim of the present study. Patients with Alzheimer's disease and patients with Parkinson's disease and dementia were matched for age, sex, and global cognitive performance. None of the patients with Alzheimer's disease had resting tremor, cogwheel rigidity, or bradykinesia. These groups were compared for cognitive performance and psychiatric symptoms. The psychiatric evaluation was completed by a psychiatrist blind to the UPDRS scores and neuropsychological findings, and included the following assessments:
The SCID is a semistructured diagnostic interview assessing signs and symptoms necessary for the major axis I DSM-III-R diagnoses.
The interview was carried out with the patient and at least one first degree relative. Based on the SCID responses, DSM-III-R diagnoses of major depression and dysthymia were made.
Hamilton depression scale (HAM-D) 16 The HAM-D is a 17 item interviewer rated scale for rating the severity of symptoms of depression.
Anosognosia questionnaire-dementia (AQ-D) 17 This string of numbers (from two to eight numbers in length) exactly as it is given. In the second part (digits backwards) the patient is asked to repeat the string of numbers (from two to eight numbers in length) in reversed order.
Wisconsin card sorting test (WCST) '9 This test measures the ability to develop and apply new concepts, and, subsequently shift sets, which requires the subjects to suppress a learned response that was previously correct and learn a new one. Assessment of the overall proficiency of the test was judged by the number of categories achieved (maximum 6).
Controlled oral word association test30
This test examines access to semantic information with time constraint. Patients were instructed to name as many words beginning with the letter F as they could in one minute. People's names and proper nouns were not permitted. The letters A and S were then presented successively, one minute being allowed for each letter. The score was the combined number of appropriate words produced in three minutes.
Raven's progressive matrices3" This test measures visuospatial reasoning.
Patients are presented with a spatial pattern problem with one part removed and four pictured inserts, one of which contains the correct pattern. The patient has to select the correct piece to match the original spatial patterns. The patterns become increasingly complex over trials. The performance score is the number correctly identified.
Purdue pegboard test32
This test assesses manipulative dexterity. The apparatus consists of a board containing two parallel rows of 25 holes each and 50 metal pegs. Patients are asked to take the pegs with the preferred (for example, right) hand and place them as quickly as possible in the right column of holes during a 30 second period. The same procedure is repeated with the non- Some limitations of our study should be pointed out. One important issue is whether patients with Parkinson's disease and dementia may have had other psychiatric diagnoses, such as Alzheimer's disease with extrapyramidal signs. This is unlikely as all our demented patients with Parkinson's disease had a positive response to levodopa, and we have recently shown that patients with Alzheimer's disease with extrapyramidal signs do not have improved motor function after levodopa.'0 Moreover, all our patients with Parkinson's disease and dementia had the onset of cognitive impairment more than one year after the onset of motor deficits. The second limitation was that we had no neuropathological confirmation of our clinical diagnoses, and whether our patients with Parkinson's disease may have the neuropathological changes of a diffuse Lewy body disease cannot be ruled out. However, whereas patients with diffuse Lewy body disease usually show no or only a mild and transient response to dopaminergic agonists,33 our patients with Parkinson's disease and dementia showed a consistently positive response to levodopa. McKeith et al have recently proposed that the presence of fluctuation cognitive impairments affecting both memory and higher cortical functions, as well as hallucinations and paranoid delusions, mild spontaneous extrapyramidal features, and repeated unexplained falls may characterise patients with Lewy body dementia.34 As this neuropsychiatric syndrome usually starts before the onset of extrapyramidal signs, it is highly unlikely that patients with Lewy body dementia were included in our group with Parkinson's disease and dementia. Another limitation is that we assessed our patients with Parkinson's disease after the intake of their regular dose of levodopa. Although their cognitive performance might have been worse without levodopa, several studies could not show significant differences in cognitive performance for on versus off levodopa among patients with Parkinson's disease. 35 The possible influence of levodopa on behavioural problems such as apathy and anosognosia should be examined in future studies. Finally, it could be argued that among patients with Parkinson's disease the HAM-D may rate extrapyramidal symptoms as depressive complaints. However, we showed the validity of the autonomic and affective symptoms of depression rated in the HAM-D for the diagnosis of dysthymia and major depression in Parkinson's disease. 36 Cummings and Benson' suggested that cortical and subcortical dementias differ in terms of motor disorders, profile of cognitive deficits, and prevalence of psychiatric disorders, but to our knowledge no systematic study of all these variables in the same cohort of patients has been carried out. Our study offers some support for the hypothesis of Cummings and 
